Evidence map›Paper›PMID 38542109›Full record

ArticleInternational journal of molecular sciences2024

Differential Impact of CD43 and CD28 on T-Cell Differentiation Depending on the Order of Engagement with the TCR.

Monserrat Alba Sandoval-Hernández, Nora Alma Fierro, José Ignacio Veytia-Bucheli, Den Alejandro Alvarado-Velázquez, Estefanía Alemán-Navarro, Erika Melchy-Pérez, Constance Auvynet, Iván Imaz-Rosshandler, Jorge Carneiro, Ernesto Perez-Rueda and 1 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 3 countries.

Monserrat Alba Sandoval-HernándezInstituto de Biotecnología, Campus Morelos, Universidad Nacional Autónoma de México (UNAM), Av. Universidad 2001, Col. Chamilpa, Cuernavaca Mor. 62210, Mexico.
Nora Alma FierroInstituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México (UNAM), Ciudad de México 04510, Mexico.ORCID 0000-0002-9719-4838
José Ignacio Veytia-BucheliInstituto de Biotecnología, Campus Morelos, Universidad Nacional Autónoma de México (UNAM), Av. Universidad 2001, Col. Chamilpa, Cuernavaca Mor. 62210, Mexico.ORCID 0000-0003-4165-2884
Den Alejandro Alvarado-VelázquezInstituto de Biotecnología, Campus Morelos, Universidad Nacional Autónoma de México (UNAM), Av. Universidad 2001, Col. Chamilpa, Cuernavaca Mor. 62210, Mexico.
Estefanía Alemán-NavarroInstituto de Biotecnología, Campus Morelos, Universidad Nacional Autónoma de México (UNAM), Av. Universidad 2001, Col. Chamilpa, Cuernavaca Mor. 62210, Mexico.
Erika Melchy-PérezInstituto de Biotecnología, Campus Morelos, Universidad Nacional Autónoma de México (UNAM), Av. Universidad 2001, Col. Chamilpa, Cuernavaca Mor. 62210, Mexico.
Constance AuvynetInstituto de Biotecnología, Campus Morelos, Universidad Nacional Autónoma de México (UNAM), Av. Universidad 2001, Col. Chamilpa, Cuernavaca Mor. 62210, Mexico.
Iván Imaz-RosshandlerInstituto Nacional de Medicina Genómica (INMEGEN), Ciudad de México 14610, Mexico.ORCID 0000-0001-5975-0138
Jorge CarneiroInstituto de Tecnologia Química e Biológica, Universidade Nova de Lisboa, Oeiras, 1169-056 Lisboa, Portugal.
Ernesto Perez-RuedaUnidad Académica del Estado de Yucatán, Instituto de Investigaciones en Matemáticas Aplicadas y en Sistemas, Universidad Nacional Autónoma de México (UNAM), Mérida 97302, Mexico.
Yvonne RosensteinInstituto de Biotecnología, Campus Morelos, Universidad Nacional Autónoma de México (UNAM), Av. Universidad 2001, Col. Chamilpa, Cuernavaca Mor. 62210, Mexico.
Weatherford College · USUniversidad Nacional Autónoma de México · MX

Funding

Consejo Nacional de Humanidades, Ciencias y Tecnologías # 220990 and # A1-S-15601UNAM/PAPIIT # IN212716 and # IN222523
6 · The paper itself

Abstract

The combination of signals from the T-cell receptor (TCR) and co-stimulatory molecules triggers transcriptional programs that lead to proliferation, cytokine secretion, and effector functions. We compared the impact of engaging the TCR with CD28 and/or CD43 at different time points relative to TCR engagement on T-cell function. TCR and CD43 simultaneous engagement resulted in higher CD69 and PD-1 expression levels than in TCR and CD28-stimulated cells, with a cytokine signature of mostly effector, inflammatory, and regulatory cytokines, while TCR and CD28-activated cells secreted all categories of cytokines, including stimulatory cytokines. Furthermore, the timing of CD43 engagement relative to TCR ligation, and to a lesser degree that of CD28, resulted in distinct patterns of expression of cytokines, chemokines, and growth factors. Complete cell activation was observed when CD28 or CD43 were engaged simultaneously with or before the TCR, but ligating the TCR before CD43 or CD28 failed to complete a cell activation program regarding cytokine secretion. As the order in which CD43 or CD28 and the TCR were engaged resulted in different combinations of cytokines that shape distinct T-cell immune programs, we analyzed their upstream sequences to assess whether the combinations of cytokines were associated with different sets of regulatory elements. We found that the order in which the TCR and CD28 or CD43 are engaged predicts the recruitment of specific sets of chromatin remodelers and TFSS, which ultimately regulate T-cell polarization and plasticity. Our data underscore that the combination of co-stimulatory molecules and the time when they are engaged relative to the TCR can change the cell differentiation program.

Indexed as

CD28 AntigensReceptors, Antigen, T-CellCell DifferentiationCytokinesLymphocyte ActivationT-LymphocytesCD28 AntigensCytokinesReceptors, Antigen, T-CellCD28CD43cytokine profilesOrder of Co-stimulationTranscription Factors

Identifiers

PMID38542109
PMCPMC10970108
OpenAlexW4392600559

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.